BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 29871255)

  • 21. A clinical study of 115 patients with extranodal natural killer/T-cell lymphoma, nasal type.
    Wu X; Li P; Zhao J; Yang X; Wang F; Yang YQ; Fang F; Xu Y; Zhang H; Wang WY; Yi C
    Clin Oncol (R Coll Radiol); 2008 Oct; 20(8):619-25. PubMed ID: 18790372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Misdiagnosis analysis: 120 patients with nasal extranodal NK/T cell lymphoma in head and neck].
    Liu PL; Cheng ZX; Lu MP; Zhang LQ; Chen HB
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Jan; 34(1):73-78. PubMed ID: 32086904
    [No Abstract]   [Full Text] [Related]  

  • 23. [Extranodal nasal type NK/T-cell lymphoma: clinicopathologic and prognostic study of 55 cases].
    Li L; Liu YH; Zhuang HG; Luo XL; Zhang F; Xu FP; Luo DL
    Zhonghua Bing Li Xue Za Zhi; 2009 Apr; 38(4):237-42. PubMed ID: 19575894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment outcomes of and prognostic factors for definitive radiotherapy with and without chemotherapy for Stage I/II nasal extranodal NK/T-cell lymphoma.
    Yang CW; Wang CW; Hong RL; Tsai CL; Yao M; Tang JL; Lin CW; Cheng AL; Kuo SH
    J Radiat Res; 2017 Jan; 58(1):114-122. PubMed ID: 27534792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early stage nasal NK/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality.
    Cheung MM; Chan JK; Lau WH; Ngan RK; Foo WW
    Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):182-90. PubMed ID: 12182990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment outcome and prognosis of 112 patients with nasal and nasopharyngeal peripheral T cell lymphomas].
    Zhang YJ; Ren ZM; Wu QL; He ZY; Huang Y; Xia YF; Lin TY; Cui NJ
    Zhonghua Xue Ye Xue Za Zhi; 2006 Apr; 27(4):217-21. PubMed ID: 16875549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural Killer/T Cell Lymphoma, Nasal Type: A Retrospective Clinical Analysis in North-Western China.
    Liang R; Wang Z; Bai QX; Gao GX; Yang L; Zhang T; Gu HT; Dong BX; Shu MM; Hao CX; Zhang N; Chen XQ
    Oncol Res Treat; 2016; 39(1-2):45-52. PubMed ID: 26891121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary non-Hodgkin's lymphoma of the nasal cavity: prognostic significance of paranasal extension and the role of radiotherapy and chemotherapy.
    Li YX; Coucke PA; Li JY; Gu DZ; Liu XF; Zhou LQ; Mirimanoff RO; Yu ZH; Huang YR
    Cancer; 1998 Aug; 83(3):449-56. PubMed ID: 9690537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short-Course Versus Long-Course Chemoradiotherapy for Stage IE-IIE Extranodal Natural Killer/T cell Lymphoma, Nasal Type: A Multicenter Retrospective Study.
    Li J; Li Y; Zhong M; Liu X; Song Y; Li J; Li K; Yi P
    Med Sci Monit; 2018 May; 24():2683-2692. PubMed ID: 29712887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiotherapy combined with chemotherapy versus radiotherapy alone for early stage nasal natural killer/T-cell lymphoma: a meta-analysis.
    Zhang B; Zhu F; Liu X; Zhao J; Li M; Li Y; Huang J; Zou L; Chang Q
    J Chemother; 2016; 28(1):65-71. PubMed ID: 25971360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cutaneous extranodal natural killer/T-cell lymphoma: a comparative clinicohistopathologic and survival outcome analysis of 45 cases according to the primary tumor site.
    Lee WJ; Jung JM; Won CH; Chang SE; Choi JH; Chan Moon K; Park CS; Huh J; Lee MW
    J Am Acad Dermatol; 2014 Jun; 70(6):1002-9. PubMed ID: 24629518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Promising clinical outcomes of sequential and "Sandwich" chemotherapy and extended involved-field intensity-modulated radiotherapy in patients with stage I
    Wang HY; Niu SQ; Yang YY; Li YY; Chen HB; Zhang YJ
    Cancer Med; 2018 Dec; 7(12):5863-5869. PubMed ID: 30484966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic impact of beta-2 microglobulin in patients with extranodal natural killer/T cell lymphoma.
    Yoo C; Yoon DH; Jo JC; Yoon S; Kim S; Lee BJ; Huh J; Lee SW; Suh C
    Ann Hematol; 2014 Jun; 93(6):995-1000. PubMed ID: 24441948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. When do we need central nervous system prophylaxis in patients with extranodal NK/T-cell lymphoma, nasal type?
    Kim SJ; Oh SY; Hong JY; Chang MH; Lee DH; Huh J; Ko YH; Ahn YC; Kim HJ; Suh C; Kim K; Kim WS
    Ann Oncol; 2010 May; 21(5):1058-63. PubMed ID: 19850636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Retrospective Analysis of Clinical Features and Prognosis of 84 Patients with Extranodal NK/T Cell Lymphoma in One Center].
    Yang QS; Zhao SH; Jiang Y; Jiang TY; Yuan SZ; Su H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1390-1396. PubMed ID: 29070113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Post-treatment plasma EBV-DNA positivity predicts early relapse and poor prognosis for patients with extranodal NK/T cell lymphoma in the era of asparaginase.
    Wang L; Wang H; Wang JH; Xia ZJ; Lu Y; Huang HQ; Jiang WQ; Zhang YJ
    Oncotarget; 2015 Oct; 6(30):30317-26. PubMed ID: 26210287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical analysis of 202 cases of extranodal NK/T-cell lymphoma].
    Ma C; Bo J; Liu T; Yao S; Zhao Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):999-1004. PubMed ID: 25130817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extranodal natural killer/T-Cell lymphoma: A population-based comparison of sinonasal and extranasal disease.
    Vazquez A; Khan MN; Blake DM; Sanghvi S; Baredes S; Eloy JA
    Laryngoscope; 2014 Apr; 124(4):888-95. PubMed ID: 24114591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of standardized uptake value on F18-FDG PET/CT in patients with extranodal nasal type NK/T cell lymphoma: A multicenter, retrospective analysis.
    Pak K; Kim BS; Kim K; Kim IJ; Jun S; Jeong YJ; Shim HK; Kim SD; Cho KS
    Am J Otolaryngol; 2018; 39(1):1-5. PubMed ID: 29056243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The effects of sequence of radiotherapy and chemotherapy on prognosis of patients with early-stage extranodal NK/T cell lymphoma (nasal type) and its individualized application].
    Yang J; Yang Y; Qi SN; Wu T; He X; Zhang LL; Wu G; Qu BL; Qian LT; Hou XR; Zhang FQ; Qiao XY; Wang H; Li GF; Zhu Y; Cao JZ; Wu JX; Zhu SY; Shi M; Su H; Zhang XM; Zhang HL; Huang HQ; Zhang YJ; Song YQ; Zhu J; Wang Y; Li YX
    Zhonghua Yi Xue Za Zhi; 2021 May; 101(17):1232-1238. PubMed ID: 34865391
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.